Naicker S, Fabian J
Division of Nephrology, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Clin Nephrol. 2010 Nov;74 Suppl 1:S51-6. doi: 10.5414/cnp74s051.
A review of the prevalence and risk factors for chronic kidney disease (CKD) in HIV infection.
A review of published literature.
High risk for development of chronic kidney disease with HIV infection are black race, CD4 count < 200 cells/mm3, HIV RNA levels > 4,000 copies/ml, family history of CKD and presence of diabetes mellitus, hypertension or hepatitis C co-infection. In 2004, the risk of developing ESRD was reported as 50 times higher in HIV-infected African-Americans than in HIV-infected whites and in 2007, African Americans accounted for nearly 90% of ESRD attributed to HIVAN. Once CKD was established, African-Americans were 18 times more likely to progress to ESRD than whites and their decline in GFR was six times more rapid than white subjects. The prevalence of CKD with HIV infection was 3.5 - 4.7% in 31 European countries, Israel and Argentina, and 1.1 - 5.6% Brazil; 18% Switzerland; 27% India and 12.3% Iran. Reported prevalence of CKD in HIV-infected patients in sub-Saharan Africa ranges from 6 - 48.5%. Few renal biopsy studies have been performed. In South Africa, HIVAN was present in variable numbers in three studies, ranging from 5 - 83% and immune complex disease in 21 - 40%. A variation in the MYH9 locus of chromosome 22 has been associated with increased risk for idiopathic FSGS, hypertensive nephrosclerosis and HIVAN and may explain much of the increased risks of ESRD and FSGS among African-Americans. A strong correlation with serum creatinine levels and progression to ESRD in HIV patients has been linked to an index of chronic damage on renal histology.
The role of genetics and variations in MYH9 gene loci in renal disease has to be established in other HIV-infected populations. The histological classification for HIV-associated chronic kidney disease requires review, as well as the utility of chronicity scores to evaluate prognosis and response to therapy of HIV-associated kidney disease.
综述HIV感染中慢性肾脏病(CKD)的患病率及危险因素。
对已发表文献进行综述。
HIV感染患者发生慢性肾脏病的高危因素包括黑人种族、CD4细胞计数<200个/立方毫米、HIV RNA水平>4000拷贝/毫升、CKD家族史以及合并糖尿病、高血压或丙型肝炎感染。2004年报告称,HIV感染的非裔美国人发生终末期肾病(ESRD)的风险比HIV感染的白人高50倍,2007年,非裔美国人占HIV相关性肾病(HIVAN)所致ESRD的近90%。一旦确诊CKD,非裔美国人进展为ESRD的可能性是白人的18倍,其肾小球滤过率(GFR)下降速度比白人快6倍。在31个欧洲国家、以色列和阿根廷,HIV感染患者中CKD的患病率为3.5% - 4.7%,巴西为1.1% - 5.6%;瑞士为18%;印度为27%;伊朗为12.3%。撒哈拉以南非洲地区HIV感染患者中CKD的报告患病率为6% - 48.5%。很少进行肾活检研究。在南非,三项研究中HIVAN的出现率各不相同,为5% - 83%,免疫复合物疾病为21% - 40%。22号染色体上MYH9基因座的变异与特发性局灶节段性肾小球硬化(FSGS)、高血压性肾硬化和HIVAN的风险增加有关,这可能解释了非裔美国人中ESRD和FSGS风险增加的大部分原因。HIV患者血清肌酐水平与进展为ESRD之间的强相关性与肾脏组织学慢性损伤指标有关。
必须在其他HIV感染人群中确定遗传学及MYH9基因座变异在肾脏疾病中的作用。HIV相关慢性肾脏病的组织学分类需要重新审视,以及慢性评分在评估HIV相关肾脏疾病预后和治疗反应方面的效用。